• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Stabilization of Blood Collection and Use in the United States

Since 1997, the biennial National Blood Collection and Utilization Survey (NBCUS) has been collecting data on blood use and collection…

May 2, 2023

Individual Risk Assessment Questions for Potential Donors at Higher Risk for HIV

In January 2023, the U.S. FDA issued draft guidance recommending individual risk-based assessments for potential donors at higher risk for…

April 26, 2023

Randomized Trial Results on Donor Sex and RBC Recipient Mortality

Observational studies and systematic reviews have found conflicting results on the association between RBC donor sex and associated transfusion recipient…

April 18, 2023

Whole Blood Derived Platelet vs. Apheresis Platelets

During the COVID-19 pandemic, the U.S. experienced significant blood product shortages. In 2019, approximately 2.5 million platelet units were collected…

April 12, 2023

Seven-Day Platelet Storage and Platelet Count Increments

Platelets must be stored at room temperature to preserve function, which makes them susceptible to bacterial contamination.  Recently, several countries…

April 4, 2023

Prothrombin Complex Concentrate Increases Risk of Thromboembolic Events in Trauma Patients

Four-factor prothrombin complex concentrate (4F-PCC) is a lyophilized concentrate of coagulation factors that is commonly used for urgent reversal of…

March 29, 2023

FDA Guidance for COVID-19 Convalescent Plasma to Remain in Effect

During the public health emergency for COVID-19, the U.S. Food and Drug Administration (FDA) issued guidance for the use of…

March 22, 2023

Acute Normovolemic Hemodilution Reduces Transfusions in Patients Undergoing Cardiac Surgery

Approximately one to two million cardiac surgery operations are performed worldwide each year accounting for about 80% of all surgical…

March 15, 2023

Gene Therapy Phase 3 Study Results for Hemophilia B

Hemophilia B is a rare, X-linked bleeding disorder caused by partial or complete deficiency of clotting factor IX.  Currently, the…

March 8, 2023

High Variability in Antibody Titer Determination in Transfusion Medicine

Antibody levels are important for many aspects of clinical care from evaluating the incompatibility of transfusions and transplants to determining…

March 2, 2023

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Interim pages omitted …
  • Page 62
  • Go to Next Page »

Primary Sidebar

Latest News

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley